|
Beta Drugs Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
1658.43 Cr.
|
P/BV
|
9.17
|
Book Value (Rs.)
|
179.17
|
|
52 Week High/Low (Rs.)
|
2170/1429
|
FV/ML
|
10/1
|
P/E(X)
|
39.10
|
|
Bookclosure
|
26/03/2025
|
EPS (Rs.)
|
42.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 100.95 | 96.14 | 96.14 | 96.14 | 96.14 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 10.09 | 9.61 | 9.61 | 9.61 | 9.61 |
| Total Share Capital | 10.09 | 9.61 | 9.61 | 9.61 | 9.61 |
| | | | | | |
| Reserves and Surplus | 187.00 | 147.50 | 113.27 | 82.73 | 59.00 |
| Total Reserves and Surplus | 187.00 | 147.50 | 113.27 | 82.73 | 59.00 |
| Total Shareholders Funds | 197.10 | 157.12 | 122.88 | 92.34 | 68.61 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 126.99 | 6.04 | 6.97 | 11.83 | 11.13 |
| Other Long Term Liabilities | 6.86 | 4.09 | 3.72 | 3.24 | 2.27 |
| Long Term Provisions | 2.56 | 2.18 | 1.83 | 1.47 | 1.14 |
| Total Non-Current Liabilities | 136.41 | 12.31 | 12.52 | 16.54 | 14.53 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 5.71 | 4.96 | 9.07 | 4.75 | 3.54 |
| Trade Payables | 71.25 | 59.27 | 40.24 | 31.95 | 20.49 |
| Other Current Liabilities | 21.46 | 17.64 | 9.54 | 8.63 | 8.91 |
| Short Term Provisions | 4.31 | 2.80 | 4.17 | 3.63 | 1.42 |
| Total Current Liabilities | 102.73 | 84.67 | 63.02 | 48.97 | 34.36 |
| | | | | | |
| Total Capital And Liabilities | 436.23 | 254.10 | 198.42 | 157.85 | 117.51 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 80.36 | 59.20 | 58.09 | 50.67 | 36.45 |
| Intangible Assets | 8.57 | 5.39 | 4.66 | 4.29 | 3.52 |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 2.81 |
| Fixed Assets | 88.93 | 64.59 | 62.76 | 54.96 | 42.78 |
| Non-Current Investments | 0.00 | 0.00 | 0.78 | 0.78 | 0.78 |
| Deferred Tax Assets [Net] | 1.83 | 1.41 | 1.20 | 0.68 | 0.65 |
| Long Term Loans And Advances | 14.14 | 10.17 | 5.95 | 4.43 | 1.41 |
| Other Non-Current Assets | 0.26 | 0.06 | 0.05 | 0.05 | 3.35 |
| Total Non-Current Assets | 105.16 | 76.23 | 70.74 | 60.89 | 48.97 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 59.77 | 49.81 | 30.62 | 22.48 | 16.04 |
| Trade Receivables | 102.58 | 79.24 | 62.72 | 45.18 | 33.88 |
| Cash And Cash Equivalents | 147.02 | 28.63 | 19.16 | 17.32 | 10.42 |
| Short Term Loans And Advances | 9.31 | 7.15 | 6.09 | 4.48 | 2.87 |
| OtherCurrentAssets | 12.39 | 13.03 | 9.09 | 7.49 | 5.32 |
| Total Current Assets | 331.08 | 177.87 | 127.68 | 96.96 | 68.53 |
| | | | | | |
| Total Assets | 436.23 | 254.10 | 198.42 | 157.85 | 117.51 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 1.73 | 1.55 | 0.77 | 1.77 | 1.59 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.78 | 0.78 | 0.78 |
